Fred's (FRED) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
Fred’s Pharmacy Reports Second Quarter 2017 Results
September 6, 2017 7:00 AM EDTContinuing to build momentum; improvements in comparable store sales trends and gross margin demonstrate the plan is beginning to work
Strategic turnaround underway; focused on reducing SG&A and driving free cash flow
MEMPHIS, Tenn.--(BUSINESS WIRE)-- Freds Inc. (NASDAQ: FRED) today reported financial results for the second quarter and six months ended July 29, 2017.
For the second quarter ended July 29, 2017, Freds recorded a net loss of approximately $29.5 million or $0.78 per share, which included the following charges totaling $30.1 million, or $0.63 per share after tax:
... More